Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Heymann

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Patient Education and Counseling|October 1, 2010
Forbidden fruitAnthony D Heymann
Patient Education and Counseling|February 5, 2011
A matter of faithAnthony D Heymann
Pharmacoepidemiology and Drug Safety|February 13, 2023
Intra-articular and soft-tissue corticosteroid injections and risk of infections: Population-based self-controlled-risk-interval designGalia Zacay, Anthony D Heymann
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 19, 2021
Re: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' responseDavid Shasha, Anthony D Heymann, Galia Zacay
Diabetes Care|July 25, 2012
Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetesAnthony D Heymann, Yossi Cohen, Gabriel Chodick
International Journal of Medical Informatics|June 27, 2009
Format change of a laboratory test order form affects physician behaviorVarda Shalev, Gabriel Chodick, Anthony D Heymann
Diabetes Care|December 2, 2020
Glycemic Control and Risk of CellulitisGalia Zacay, Fabienne Hershkowitz Sikron, Anthony D Heymann
European Journal of Epidemiology|February 5, 2004
The epidemiology of diabetes in a large Israeli HMOGabriel Chodick, Anthony D Heymann, Varda Shalev, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 4, 2005
The direct medical cost of diabetes in IsraelGabriel Chodick, Anthony D Heymann, Francis Wood, et al.
Health Economics Review|November 16, 2013
The high cost of celiac disease in an Israeli Health Maintenance OrganizationAnthony D Heymann, Moshe Leshno, Ronit Endevelt, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Patient Education and Counseling|October 1, 2010
Forbidden fruitAnthony D Heymann
Patient Education and Counseling|February 5, 2011
A matter of faithAnthony D Heymann
Pharmacoepidemiology and Drug Safety|February 13, 2023
Intra-articular and soft-tissue corticosteroid injections and risk of infections: Population-based self-controlled-risk-interval designGalia Zacay, Anthony D Heymann
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 19, 2021
Re: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' responseDavid Shasha, Anthony D Heymann, Galia Zacay
Diabetes Care|July 25, 2012
Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetesAnthony D Heymann, Yossi Cohen, Gabriel Chodick
International Journal of Medical Informatics|June 27, 2009
Format change of a laboratory test order form affects physician behaviorVarda Shalev, Gabriel Chodick, Anthony D Heymann
Diabetes Care|December 2, 2020
Glycemic Control and Risk of CellulitisGalia Zacay, Fabienne Hershkowitz Sikron, Anthony D Heymann
European Journal of Epidemiology|February 5, 2004
The epidemiology of diabetes in a large Israeli HMOGabriel Chodick, Anthony D Heymann, Varda Shalev, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 4, 2005
The direct medical cost of diabetes in IsraelGabriel Chodick, Anthony D Heymann, Francis Wood, et al.
Health Economics Review|November 16, 2013
The high cost of celiac disease in an Israeli Health Maintenance OrganizationAnthony D Heymann, Moshe Leshno, Ronit Endevelt, et al.
Pageof 5